Genomics

Dataset Information

0

DNA structure-specific endonuclease FEN1 as a novel drug target in tamoxifen resistant breast cancer.


ABSTRACT: Estrogen receptor α (ERα) is a key transcriptional regulator in the majority of breast cancers. ERα-positive patients are frequently treated with tamoxifen, but resistance is common. In this study, we refined a previously identified 111-gene outcome prediction-classifier, revealing FEN1 as the strongest determining factor in ERα-positive patient prognostication. FEN1 levels were predictive of outcome in tamoxifen-treated patients, and FEN1 played a causal role in ERα-driven cell growth. FEN1 impacted the transcriptional-activity of ERα by facilitating coactivator recruitment to the ERα transcriptional complex. FEN1 blockade induced proteasome-mediated degradation of activated ERα, resulting in loss of ERα-driven gene expression and eradicated tumor cell proliferation. Finally, a high-throughput 465,195 compound screen identified a novel FEN1 inhibitor, which effectively blocked ERα-function and inhibited proliferation of tamoxifen-resistant cell lines as well as ex-vivo cultured ERα-positive breast tumors. Collectively, these results provide therapeutic proof-of-principle for FEN1 blockade in tamoxifen-resistant breast cancer.

ORGANISM(S): Homo sapiens

PROVIDER: GSE95302 | GEO | 2020/06/01

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2015-12-12 | GSE73320 | GEO
2020-10-22 | GSE148186 | GEO
2023-09-13 | GSE217190 | GEO
2015-03-07 | GSE66607 | GEO
2021-01-11 | GSE164529 | GEO
2023-04-12 | GSE154268 | GEO
2016-05-28 | E-GEOD-79738 | biostudies-arrayexpress
2019-05-26 | GSE112883 | GEO
2023-02-06 | GSE220776 | GEO
2019-02-09 | PXD010314 | Pride